The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Open accessAbstract
which predominantly occurred in young males after the second dose, an ACIP meeting was rapidly convened to review reported cases of myocarditis and pericarditis and discuss the benefits and risks of mRNA COVID-19 vaccination in the United States. Myocarditis is an inflammation of the heart muscle; if it is accompanied by pericarditis, an inflammation of the thin tissue surrounding the heart (the pericardium), it is referred to as myopericarditis. Hereafter, myocarditis is used to refer to myocarditis, pericarditis, or myopericarditis. On June 23, 2021, after reviewing available evidence including that for risks of myocarditis, ACIP determined that the benefits of using mRNA COVID-19 vaccines under the FDA's EUA clearly outweigh the risks in all populations, including adolescents and young adults. The EUA has been modified to include information on myocarditis after receipt of mRNA COVID-19 vaccines. The EUA fact sheets should be provided before vaccination; in addition, CDC has developed patient and provider education materials about the possibility of myocarditis and symptoms of concern, to ensure prompt recognition and management of myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, our study confirms findings of previ ously identified rare cases of myocarditis and pericarditis following first and second doses of mRNA vaccines [21 -23,34].”
From COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals (2024) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“In women aged 18–24, mRNA COVID-19 vaccination would prevent 1127 hospitalisations, 93 ICU admissions and 13 deaths, while causing 4–5 myocarditis cases. 25”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
In the citing paper
“1 million mRNA COVID-19 vaccination doses would prevent 936 hospitalisations, 215 intensive care unit (ICU) admissions and 13 deaths, while simultaneously leading to 15–18 vaccine-associated myocarditis cases.”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627
Self-citationPreliminary evidence on long COVID in children
Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
Payne, A. B., Gilani, Z., Godfred‐Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M. M., Thomas, D., Magleby, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16420 · Cited by 395
Self-citationThe Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349
Self-citationThe effects of gender and age on occurrence of clinically suspected myocarditis in adulthood
Kytö, V., Sipilä, J., & Rautava, P. (2013) · Heart · doi:10.1136/heartjnl-2013-304449 · Cited by 124
Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016
Vasudeva, R., Bhatt, P. J., Lilje, C., Desai, P., Amponsah, J. K., Umscheid, J., Parmar, N. G., Bhatt, N. S., Adupa, R., Pagad, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.03.019 · Cited by 53
Cited by
Sorted by citations
Items 301–400 of 586
Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male
Sütçü, M., Gül, D., Atík, F., & Kara, M. (2022) · Malawi Medical Journal · doi:10.4314/mmj.v34i2.13 · Cited by 6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management
Restrepo, M. I., Marín‐Corral, J., Rodríguez, J. J. B., Restrepo, V., & Cavallazzi, R. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1760096 · Cited by 7
Acute Lymphocytic Myocarditis in a Young Male Post-COVID-19
Bohné, M., Bohnen, S., Willems, S., Klingel, K., Kivelitz, D. E., & Bahlmann, E. (2023) · Case Reports in Cardiology · doi:10.1155/2023/7646962 · Cited by 8
Li, K., Huang, B., Ji, T., Xu, S.-G., & Jiang, W. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s323280 · Cited by 6
Mormile, R. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2044305 · Cited by 6
Advances in mRNA vaccine research in the field of quality control
Huang, D., Li, N., & Dong, X. W. (2024) · Biologicals · doi:10.1016/j.biologicals.2024.101799 · Cited by 5
Kitano, T., Salmon, D. A., Dudley, M. Z., Thompson, D. A., & Engineer, L. D. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae002 · Cited by 5
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza
Nham, E., Noh, J. Y., Park, O. H., Choi, W. S., Song, J. Y., Cheong, H. J., & Kim, W. J. (2024) · Vaccines · doi:10.3390/vaccines12050514 · Cited by 6
Sarbazi, E., Masoudi, N., Mehri, A., Esfanjani, R. M., Azizi, H., Soleimanpour, M., Pouraghaei, M., & Soleimanpour, H. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04816-w · Cited by 5
Acute Bilateral Orbital Myositis Following Covid 19 Vaccination
Murphy, G. S. P., Gounder, P., & Rajak, S. N. (2022) · Orbit · doi:10.1080/01676830.2022.2042825 · Cited by 5
Chest Pain and Suspected Myocarditis Related to COVID-19 Vaccination in Adolescents—A Case Series
Roh, D. E., Na, H., Kwon, J. E., Choi, I., Kim, Y. H., & Cho, H. J. (2022) · Children · doi:10.3390/children9050693 · Cited by 5
Badaró, R. J. D. S., Novaes, G. C., Andrade, A. C., Neto, C. A. D. A., Machado, B. A. S., Barbosa, J. D. V., & Soares, M. B. P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1071239 · Cited by 5
Luo, J., Hur, K., Salone, C., Huang, N., Burk, M. L., Pandey, L., Thakkar, B., Donahue, M., & Cunningham, F. E. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad268 · Cited by 5
Unmasking the enigma: An in-depth analysis of COVID-19 impact on the pediatric population
Ahmed, I. S., Tapponi, S. L., Widatallah, M. E., Alakkad, Y. M., & Haider, M. A. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.06.017 · Cited by 5
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
Kassianos, G. C., MacDonald, P., Aloysius, I., & Pather, S. (2024) · Vaccines · doi:10.3390/vaccines12010057 · Cited by 5
Reflections on the Advisory Committee on Immunization Practices During the COVID-19 Pandemic
Poehling, K. A., & Lee, G. M. (2024) · Academic Pediatrics · doi:10.1016/j.acap.2024.06.019 · Cited by 5
Self-citationHaeder, S. F., & Yackee, S. W. (2025) · Annual Review of Law and Social Science · doi:10.1146/annurev-lawsocsci-062124-122046 · Cited by 5
Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes
Chavda, V. P., Chhabria, M. T., & Apostolopoulos, V. (2022) · Biologics · doi:10.3390/biologics2030013 · Cited by 5
Tan, L. J., Koh, C. P., Lai, S. K., Poh, W. C., Othman, M. S., & Hussin, H. (2022) · Forensic Science International · doi:10.1016/j.forsciint.2022.111469 · Cited by 6
Yamamoto, H., Takahashi, M., & Isogai, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13881 · Cited by 4
Bilotta, C., Perrone, G., Zerbo, S., & Argo, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.874687 · Cited by 5
Nogawa, S., Kanamori, H., Tokuda, K., Kawafune, K., Chijiiwa, M., Saito, K., & Takahashi, S. (2021) · medRxiv · doi:10.1101/2021.11.30.21267043 · Cited by 5
Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccinePreprint
Wanlapakorn, N., Yorsaeng, R., Phowatthanasathian, H., Suntronwong, N., Kanokudom, S., Sudhinaraset, N., & Poovorawan, Y. (2021) · medRxiv · doi:10.1101/2021.11.20.21266644 · Cited by 4
New Onset Glomerular Disease Post–COVID-19 Vaccination: Is There a Link?
Radhakrishnan, Y., & Zand, L. (2023) · Kidney360 · doi:10.34067/kid.0000000000000073 · Cited by 5
Mues, K. E., Zhou, C. K., Gerber, J. E., van Hunsel, F. P. A. M., Klein, N. P., Izurieta, H. S., & Chen, R. T. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127691 · Cited by 4
Tham, M. Y., Chan, C. L., Toh, D., Poh, J. W. W., Lim, A., Soh, S. B. L., Peck, L. F., Foo, B., Ng, A., Ng, P., et al. (2024) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2023-089 · Cited by 4
Immune Dysregulation in the Oral Cavity during Early SARS-CoV-2 Infection
Graves, C. L., Babikow, E., Ghaltakhchyan, N., Ngo, T. Q., Liu, C., Wang, L., Shoji, A., Bocklage, C., Phillips, S. T., Markovetz, M. R., et al. (2024) · Journal of Dental Research · doi:10.1177/00220345241271943 · Cited by 4
Babicki, M., Malchrzak, W., & Mastalerz–Migas, A. (2022) · Vaccines · doi:10.3390/vaccines10030381 · Cited by 5
Posicionamento sobre Segurança Cardiovascular das Vacinas contra COVID-19 - 2022
Moreira, H. G., de Oliveira, M. T., Valdigem, B. P., Martins, C. N., & Polanczyk, C. A. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220179 · Cited by 4
Güven, S. C., Karakaş, Ö., Atalar, E., Konak, H. E., Dağlı, P. A., Erdoğan, E. K., Armağan, B., Gök, K., Doğan, İ., Maraş, Y., et al. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14349 · Cited by 4
COVID-19 vaccination and cardiac dysfunction
Leowattana, W., & Leowattana, T. (2022) · World Journal of Cardiology · doi:10.4330/wjc.v14.i6.343 · Cited by 4
A case series of acute myocarditis associated with SARS-CoV-2 mRNA vaccination
Abellan, C., Vivekanantham, H., Mahmoudi, A., Doll, S., & Arroyo, D. (2021) · Cardiovascular Medicine · doi:10.4414/cvm.2021.02181 · Cited by 4
Rao, K., Arustamyan, M., Walling, A., Christodoulidis, G., Ashwath, M. L., Hagedorn, J., & Priya, S. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad090 · Cited by 4
Sim, J.-Y., 김, 승., & Kim, E. K. (2023) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2023.0032 · Cited by 4
ATAGI Targeted Review 2021: the national COVID-19 vaccination program
Jayasinghe, S. H., Patel, C., Armstrong, L., Chiu, C., Macartney, K. K., Flanagan, K. L., Gibney, K. B., Giles, M., Crawford, N. W., Cheng, A., et al. (2023) · Communicable Diseases Intelligence · doi:10.33321/cdi.2023.47.20 · Cited by 3
Dove, M. L., Slesnick, T. C., Oster, M. E., Hashemi, S., Patel, T., & Wilson, H. C. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.113462 · Cited by 4
Self-citationRuggiero, R., Donniacuo, M., Mascolo, A., Gaio, M., Cappetta, D., Rafaniello, C., Docimo, G., Riccardi, C., Izzo, I., Ruggiero, D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061584 · Cited by 4
Post-vaccine COVID-19 acute myocarditis: case reports and literature review
Bouchaala, A., Nguadi, J., Benhlima, A., Arfaoui, M., Hamzaoui, H. E., & Alilou, M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.192.35425 · Cited by 4
Cheng, M.-Y., Ho, H.-C., Hsu, J., Wang, Y., Chen, L., Lim, S., Liao, M., & Ro, L. (2024) · Diseases · doi:10.3390/diseases12030060 · Cited by 3
Al‐Rousan, N., & Al-Najjar, H. M. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101564 · Cited by 5
Proposals to Accelerate Novel Vaccine Development for Children
Permar, S. R., Creech, C. B., Edwards, K. M., & Walter, E. B. (2021) · PEDIATRICS · doi:10.1542/peds.2021-054593 · Cited by 4
Case report: mRNA COVID-19 vaccine-related acute pericarditis with evolution to myopericarditis
Riddell, C., Edwards, N. C., & Stewart, R. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac298 · Cited by 4
Acute myocarditis after COVID-19 vaccination
Saadi, S. M., Bossei, A. A., & Alsulimani, L. K. (2022) · Saudi Medical Journal · doi:10.15537/smj.2022.43.11.20220292 · Cited by 4
Kim, A., Kim, S., Song, J.-E., Hwang, S., Nam, E., & Kwon, K. T. (2023) · Vaccines · doi:10.3390/vaccines11020363 · Cited by 5
Chest pain attendances to a Paediatric Emergency Department pre- and post-COVID-19 vaccination
Tan, J. Z., Zhang, D. Z., Sundararaghavan, S., Ganapathy, S., Choo, J. T. L., Rajendram, M. F., & Chong, S. (2023) · Translational Pediatrics · doi:10.21037/tp-23-230 · Cited by 4
Political orientation of online media sources and reporting of Covid-19 vaccine myocarditis
Matsumura, A., Garg, R., Hussain, M., & Matsumura, M. E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296295 · Cited by 4
Bianchi, F. P., Rizzi, D., Daleno, A., Stefanizzi, P., Migliore, G., & Tafuri, S. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.02.003 · Cited by 4
Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination
Walters, C. G., Jaiswal, D. D., Hu, T. X., & Kim, S. S. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.847 · Cited by 4
Side Effects of Pfizer-BioNTech COVID-19 Vaccine among Libyan Young Adults: Observational Study
Shailabi, T. I. M., Borwis, E. O., Majeed, N. S., Bubtina, N. H., Betamar, N. M., & Abdeldaim, G. M. K. (2022) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2022.101005 · Cited by 4
COVID Vaccines in Adolescents and Young Adults
(2022) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.03.009 · Cited by 4
New-onset Glaucoma Following Moderna COVID-19 Vaccination
Su, Y.-W., Yeh, S.-J., & Chen, M. (2023) · JOURNAL OF CURRENT GLAUCOMA PRACTICE · doi:10.5005/jp-journals-10078-1408 · Cited by 4
Acute cardiac side effects after COVID-19 mRNA vaccination, a case seriesPreprint
Freise, N. F., Kivel, M., Grebe, O. C., Meyer, C., Wafaisade, B., Peiper, M., Zeus, T., Schmidt, J., Neuwahl, J., Jazmati, D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1157175/v1 · Cited by 4
Vaccinating adolescents in England: a risk-benefit analysisPreprint
Gurdasani, D. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/grzma · Cited by 4
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination
Cavalli, M., Eriksson, N., Baron, T., Yalçınkaya, A. S., Landegren, N., Brodin, P., Hallberg, P., & Wadelius, M. (2025) · npj Vaccines · doi:10.1038/s41541-025-01139-4 · Cited by 3
Yoon, S. K., Ellsworth, G. L., Battan-Wraith, S., Phillips, A. L., Fink, R. V., Griffin, J., Rowley, E. A. K., Mckell, J., Smith, A. S., Campbell, R., et al. (2026) · JMIR Research Protocols · doi:10.2196/80858 · Cited by 3
Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children
Mariani, M., Caorsi, R., Consolaro, A., Brisca, G., Sticchi, C., Gattorno, M., Castagnola, E., & Ravelli, A. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01335-1 · Cited by 3
A COVID-19 vaccination program for high-risk children aged 12–17 years in Curacao
Janssen, L. J. F., Lo-A-Njoe, S. M., ten Pas, C., & Duits, A. J. (2023) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2023.129 · Cited by 3
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
Satyam, S. M., El‐Tanani, M., Bairy, L. K., Rehman, A., Srivastava, A., Kenneth, J. M., & Prem, S. M. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09954-2 · Cited by 3
An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination
Chowdhury, P., Bhattacharya, S., Gogoi, B., Veeranna, R. P., & Kumar, S. (2022) · Vaccines · doi:10.3390/vaccines10101639 · Cited by 3
Valore, L., Junker, T., Heilmann, E., Zuern, C. S., Streif, M., Drexler, B., Arranto, C., Halter, J. P., & Berger, C. T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1135848 · Cited by 5
Tome, J., Cowan, L., & Fung, I. C. (2023) · Microorganisms · doi:10.3390/microorganisms11051099 · Cited by 4
COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
Zwiers, L. C., Ong, D. S. Y., & Grobbee, D. E. (2023) · Global Heart · doi:10.5334/gh.1252 · Cited by 3
Wittawatmongkol, O., Bunjoungmanee, P., Kosalaraksa, P., Laoprasopwattana, K., Boonsathorn, S., Chantasrisawad, N., Sudjaritruk, T., Niyomnaitham, S., Senawong, S., Srisutthisamphan, K., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.08.021 · Cited by 3
Mastrolia, M. V., Cillia, C. D., Orlandi, M., Abu‐Rumeileh, S., Maccora, I., Maniscalco, V., Marrani, E., Pagnini, I., & Simonini, G. (2023) · Medicina · doi:10.3390/medicina59112027 · Cited by 5
Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
Baritussio, A., Giordani, A. S., Basso, C., Vicenzetto, C., Lorenzoni, G., Gasparin, M., Iliceto, S., Scarpa, B., Gregori, D., Marcolongo, R., et al. (2023) · Vaccines · doi:10.3390/vaccines11121742 · Cited by 3
Confronting Health Misinformation Surrounding COVID-19 Vaccines in the State of Florida
Haller, M. J., Rubin, D. A., & Hitchings, M. D. T. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08726-6 · Cited by 3
Myocarditis in children 2024, new themes and continued questions
Goldberg, J. F., Spinner, J. A., & Soslow, J. H. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001151 · Cited by 4
Pham‐Huy, A., Bowes, J., Russell, K., Amira, A., & Lai, L. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.06.057 · Cited by 3
Abdella, W. S., Selim, A. N., Diab, S., Qobeia, E., & Elgazzar, A. F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-61939-7_9 · Cited by 3
COVID-19 and the Unraveling of Experimental Medicine - Part II
Thorp, K. E., & Thorp, J. A. (2022) · The Gazette of Medical Sciences · doi:10.46766/thegms.pubheal.22022804 · Cited by 3
Mapelli, M., Amelotti, N., Andreini, D., Baggiano, A., Campodonico, J., Moltrasio, M., Majocchi, B., Mantegazza, V., Vignati, C., Ribatti, V., et al. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartj/suac018 · Cited by 3
Fritz, R., Betageri, O., Chakrala, T. S., Kim, J. N., Al‐Ani, M. A., & Omar, A. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-249533 · Cited by 3
Post-COVID mRNA vaccine myocarditis in children: report of two cases
Shamekh, A., Powell, C., Ashabani, A., & Abdelgadir, I. S. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-253383 · Cited by 3
Wang, D., Li, L., Cao, J., Hu, S., Liu, C., Feng, Z., & Li, Q. (2023) · Pediatric Pulmonology · doi:10.1002/ppul.26336 · Cited by 3
Galea, N., Cundari, G., Dedda, E. D., Chimenti, C., Aquaro, G. D., Barison, A., Cau, R., Cesare, E. D., Renzi, P. D., Esposito, A., et al. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-02799-w · Cited by 3
Transient Myopericarditis Following Vaccination for COVID-19
Gill, J., Mallari, A. J. P., & Zahra, F. (2022) · Journal of Medical Cases · doi:10.14740/jmc3876 · Cited by 3
Effects of Biological Sex and Pregnancy on SARS-CoV-2 Pathogenesis and Vaccine Outcomes
Shapiro, J. R., Roberts, C. W., Arcovio, K., Reade, L., Klein, S. L., & Dhakal, S. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_4 · Cited by 4
Acute Myocarditis Following the Third Dose of SARS-CoV-2 Vaccine; A Case ReportPreprint
Mohammadi, A., Rezaiye, M., & Goharrizi, M. A. S. B. (2022) · Research Square · doi:10.21203/rs.3.rs-1220786/v1 · Cited by 3
Myocarditis and pericarditis risk after covid-19 vaccination
Luo, J., & Gellad, W. F. (2022) · BMJ · doi:10.1136/bmj.o1554 · Cited by 3
2022 Top Images in Radiology: Radiology In Training Editors' Choices
Lennartz, S., Li, P., Consul, N., & Lee, S. I. (2022) · Radiology · doi:10.1148/radiol.229031 · Cited by 3
Choi, S., Yu, S., Kim, J., Choi, M., Choi, Y. Y., Choi, J. H., Yun, K. W., & Choe, Y. J. (2024) · Pediatric Infection & Vaccine · doi:10.14776/piv.2024.31.e16 · Cited by 3
A brief history of the COVID-19 pandemic: perspectives in risk science and data analytics
Trump, B. D., Keenan, J. M., & Linkov, I. (2025) · Journal of Risk Research · doi:10.1080/13669877.2025.2569437 · Cited by 2
Anyalechi, G. E., Marquez, P. L., Rubin, M. N., Johannsen, S.-A. P., Kohlman, K., Gunta, J., Works, K. N., Woo, J., Romanson, B., Crist, M. B., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128569 · Cited by 2
Self-citationStraus, W. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2653369 · Cited by 3
Epidemiology and Control: From Principles to Pandemics
Kaslow, R. A., & Bell, D. M. (2022) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_1-1 · Cited by 2
COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report
Voltarelli, C. L., Silva, L., Longo, M., Ferraria, S., Martins, L. L., Nazar, G. A., Magalhães, T. A., Miyazima, R., & Marques, G. L. (2022) · Cureus · doi:10.7759/cureus.28440 · Cited by 2
Fujibayashi, K., & Kajinami, K. (2022) · Clinical Medicine Insights Case Reports · doi:10.1177/11795476221138648 · Cited by 2
Sousa, J. P., Roque, D., Guerreiro, C., & Teixeira, R. P. (2023) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2023.01.003 · Cited by 2
Schroth, D., Garg, R., Bocova, X., Hansmann, J., Haass, M., Yan, A. T.-K., Fernando, C., Chacko, B. R., Oikonomou, A., White, J. A., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1204232 · Cited by 2
Mori, M., Tanaka, A., Maeda, K., Saito, S., Furuhashi, K., & Maruyama, S. (2023) · CEN Case Reports · doi:10.1007/s13730-023-00813-7 · Cited by 2
Kim, E., Kim, H. J., & Han, D. H. (2023) · Psychiatry Investigation · doi:10.30773/pi.2023.0116 · Cited by 2
Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study
Montarello, N. L., Wong, H. Z., Jeffries, A., Perkins, G. B., Hissaria, P., Stokes, M. B., Raith, E. P., Teo, K. S. L., & Bradley, J. (2023) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2023.06.005 · Cited by 2
Cardiovascular Safety of the COVID-19 Vaccine in Team USA Athletes
Shah, A. B., Rizzo, S. M., Finnoff, J. T., Baggish, A. L., & Adams, W. M. (2023) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381231208677 · Cited by 2
Adverse effects of COVID-19 vaccines in university students
Jongmekwamsuk, K., Hanvivattanakul, S., Vanichanan, J., & Khawcharoenporn, T. (2024) · F1000Research · doi:10.12688/f1000research.145862.1 · Cited by 1
Searching COVID-19 Clinical Research Using Graph Queries: Algorithm Development and Validation
Invernici, F., Bernasconi, A., & Ceri, S. (2024) · Journal of Medical Internet Research · doi:10.2196/52655 · Cited by 2
Lou, Z., Shi, Y., Guo, X., Jin, Z., Huang, J., Hu, Y., Liu, X., Zhu, J., Kuang, R., & You, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c04953 · Cited by 2
mRNA Vaccines: Immunology and Present and Future Potential
Khan, O. F., Couture‐Senécal, J., Lau, Y. M. A., Oproescu, A.-M., Pang, J., Tilstra, G., & Walz, B. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-62772-9_5 · Cited by 2
A COVID-19 primer for primary care clinicians
Burkhardt, M. C., Winter, K., Alter, S. J., & Klatte, J. M. (2022) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2022.101180 · Cited by 2
The Significance of COVID-19 Vaccine Booster Dose. A Comparative Review
Raslan, M., Eslam, M. S., Sara, A. R., & Sabri, N. A. (2022) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2022.06.0872 · Cited by 2
Bloise, S., Marcellino, A., Martucci, V., Sanseviero, M., Testa, A., Giudice, E. D., Spatuzzo, M., Sermoneta, D., Ventriglia, F., & Lubrano, R. (2022) · Children · doi:10.3390/children9070993 · Cited by 2
Metadata
- Authors
- Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., Scobie, H. M., Moulia, D., Markowitz, L. E., Wharton, M., McNally, V. V., Romero, J. R., Talbot, H. K., Lee, G. M., Daley, M. F., & Oliver, S. E.
- Affiliations
- Kaiser Permanente (US)
- Corresponding author
- Gargano, Julia W.
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-07-09
- Volume
- 70
- Issue
- 27
- Pages
- 977-982
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC8312754
- OpenAlex
- W3178327314
- Cited by
- 587
- References
- 7
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 66 · 2023: 138 · 2022: 239 · 2021: 92
- FWCI
- 89.67
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- U.S. Department of Health and Human Services
- Minnesota Department of Health
- Council of State and Territorial Epidemiologists
- Kaiser Permanente
- Vanderbilt University
- Emory University
- George Washington University
- Nationwide Children's Hospital
- University of Washington
- Johns Hopkins University (COVID-19)
- Drexel University
- American Pharmacists Association
- Saint Louis University
- Public Health Agency of Canada
- Marshfield Clinic Research Institute
- Kaiser Permanente Washington Health Research Institute
- Northwell Health
- Public Health Agency
- National Institutes of Health (COVID-19)
- Centers for Disease Control and Prevention
- School of Medicine, Vanderbilt University
- University of California, Los Angeles
- College of Medicine, Drexel University
- Wake Forest School of Medicine
- Research Institute, Nationwide Children's Hospital
- Biomedical Advanced Research and Development Authority
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 mRNA vaccine, myocarditis, pericarditis, myopericarditis, vaccine safety, Advisory Committee on Immunization Practices, emergency use authorization, adolescents and young adults, patient and provider education
- MeSH terms
- COVID-19, COVID-19 Vaccines, mRNA Vaccines, Adolescent, Adult, Centers for Disease Control and Prevention, U.S., Child, Female, Humans, Immunization, Male, Myocarditis, United States, Vaccines, Synthetic, Adverse Drug Reaction Reporting Systems, Practice Guidelines as Topic, Advisory Committees, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review